Marubi(SH:603983) Zheng Quan Zhi Xing·2025-08-27 00:07Group 1: Marubi Biotechnology - Marubi Biotechnology is expanding its audience on Douyin through targeted content delivery, leading to an increase in its traffic pool [1] - The company is undergoing organizational restructuring, optimizing its talent team and updating its compensation management system to support growth [1] - The strategic investment in the second quarter is expected to convert into results in the fourth quarter, with the "Lianhuo" brand entering a normal development phase and plans to continue launching new products in the second half of the year [1] Group 2: Tianfu Communication - In the first half of 2025, Tianfu Communication achieved revenue of 2.456 billion yuan, a year-on-year increase of 57.84%, and a net profit of 899 million yuan, up 37.46% [2] - The growth in active business is primarily driven by the increased delivery of high-speed active products, with the company continuously expanding its new customer base [2] - The company's gross margin has decreased due to changes in product structure, with an increased proportion of revenue from active products [2] Group 3: Plit - Plit reported significant growth in the first half of 2025, driven by a full order book in modified materials and the release of new production capacity [3] - The renewable energy segment saw a year-on-year revenue increase of 21.32%, supported by high demand for square batteries and an increase in orders for sodium-ion batteries [3] - The company is actively applying modified materials in the robotics sector, with some materials already being supplied in bulk to industrial robots [3]